Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 3;11(8):e00198. doi: 10.14309/ctg.0000000000000198

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 2. — B1 and L3 disease are associated with low CD206⁺/CD206⁻ ratios throughout the ileocecal mesentery. (a) CD206 ratios in patients with L1 (n = 28) and L3 (n = 10) disease, compared with ulcerative colitis (UC)/non-inflammatory bowel disease (IBD) controls (n = 7). (b) CD206⁺/CD206⁻ ratios in patients with recurrence, defined as a Rutgeerts score ≥ i2b (n = 9), vs patients without recurrence, defined as a Rutgeerts score ≤ i2a (n = 26), compared with UC/non-IBD controls (n = 7). (c) CD206⁺/CD206⁻ ratios in patients with B1 (n = 4), B2 (n = 20), and B3 (n = 14) disease, compared with UC/non-IBD controls (n = 7). *P < 0.05; **P < 0.01, compared with UC/non-IBD controls as calculated by t test.